MindBio Therapeutics Delivers First Edge AI Intoxication Detection Kiosk Prototypes for Workplace Safety

MindBio Therapeutics has completed and delivered its first prototype Edge AI Intoxication and Fatigue Detection Kiosks, which use voice analysis to detect impairment in safety-sensitive workplaces, presenting a faster, less invasive alternative to traditional testing methods.

SD Metrowire Staff
Technology
MindBio Therapeutics Delivers First Edge AI Intoxication Detection Kiosk Prototypes for Workplace Safety

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) has reached a significant milestone with the completion and delivery of its first prototype Edge AI Intoxication and Fatigue Detection Kiosks. These kiosks combine proprietary hardware and software to assess intoxication and fatigue through short voice samples analyzed by artificial intelligence. The technology is designed for workplace safety applications, targeting industries such as mining, aviation, construction, transportation, and law enforcement, where safety-sensitive operations require large-scale screening.

The prototypes have entered a testing and validation phase involving collaboration with industry participants, speech specialists, and software engineers. The objective is to refine the company’s predictive models and evaluate performance under real-world operating conditions before broader commercial deployment. The AI models have been trained on more than 50 million data points and analyze over 140 acoustic markers associated with impairment. This positions the technology as a faster and less invasive alternative to traditional drug and alcohol testing methods.

According to a recent company announcement, the kiosks use artificial intelligence and voice analysis to detect potential intoxication and fatigue. The company is positioning this technology as a crucial tool for enhancing workplace safety. More details are available in the company’s newsroom at https://nnw.fm/MBQIF.

The development of these kiosks represents a step forward in the commercialization of voice-based impairment detection technology. By leveraging edge AI, the kiosks can process data locally, reducing latency and enhancing privacy. This approach is particularly important in environments where rapid and non-intrusive screening is essential.

MindBio Therapeutics is a biotechnology company focused on developing innovative solutions for health and safety. The Edge AI Intoxication Detection Kiosk prototypes are the result of extensive research and development. For more information, visit the company’s newsroom at https://nnw.fm/iMjA8.

The implications of this announcement are significant for workplace safety. If successful, the technology could provide a reliable, scalable, and non-invasive method for detecting impairment, potentially reducing accidents and improving safety in high-risk industries. The shift from traditional testing methods to AI-driven voice analysis could also lower costs and increase the frequency of screening, leading to safer work environments.

Blockchain Registration

QR Code for Blockchain Registration